All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| CNC / Centene Corporation
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US00C4U1L353 / Mylan N.V.
|
|
|
|
|
|
|
|
| XCUR / Exicure, Inc.
|
|
|
|
|
|
|
|
| ATRS / Antares Pharma Inc
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| 110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
|
|
|
|
|
|
|
|
| DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
| EHTH / eHealth, Inc.
|
|
|
|
|
|
|
|
| ESPR / Esperion Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MRNS / Marinus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
| 0PP / Portola Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
| AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| REGN / Regeneron Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
| TWST / Twist Bioscience Corporation
|
|
|
|
|
|
|
|
| US92220P1057 / Varian Medical Systems, Inc.
|
|
|
|
|
|
|
|
| BIO / Bio-Rad Laboratories, Inc.
|
|
|
|
|
|
|
|
| UNH / UnitedHealth Group Incorporated
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
| NCNA / NuCana plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US60877T1007 / Momenta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| VRCA / Verrica Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| GH / Guardant Health, Inc.
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| BAX / Baxter International Inc.
|
|
|
|
|
|
|
|
| GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VRAY / ViewRay Inc.
|
|
|
|
|
|
|
|
